Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus

December 2016

You'll get requests to switch from Lantus to Basaglar (BAY-zuh-glar).

Basaglar is a new brand of glargine U-100...NOT a Lantus generic.

But Lantus will be dropped from some 2017 formularies since it costs about $370 per 5-pen box...compared to about $320 for Basaglar.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Immunizations Give Just Two Doses of HPV Vaccine to Most Children
Statins Ensure Appropriate Diabetes Patients Are on Target Statin Doses
Infectious Diseases Hold Off on Antibiotics for Some Kids with Acute Otitis Media
Diabetes Don't Use a Non-Insulin Diabetes Med in Most Type 1 Patients
Gout Consider an Oral Steroid Instead of an NSAID for Acute Gout
Pregnancy Use Enoxaparin in Pregnant Women at Risk for Thromboembolism
Supplements Tell Patients Not to Rely on Turmeric
Vaccines Explain Why Patients Shouldn't Wait to Get Shingrix Instead of Zostavax
Women's Health Support Breastfeeding Mothers by Offering Help With Common Problems
Cancer Opioids Are Still Appropriate for Moderate or Severe Cancer Pain
Insulin Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus
Adverse Events Document Allergic Reactions to Excipients in the Patient's Chart
Heart Failure Don't Add Tolvaptan (Samsca) to Improve Diuresis in HF Patients